{"cdcTestId":"2020-0027","testcaseName":"Dose #2 of Pfizer Covid-19 Vaccine at 21 - 5 days (age 5 years)","vaccineGroup":"COVID-19","evaluationTestType":"Interval: Below Absolute Minimum","forecastTestType":"Recommended based on minimum interval from invalid dose","assessmentDate":"2022-10-19T00:00:00","patient":{"dob":"2017-10-03T00:00:00","gender":"M"},"evaluation":{"seriesStatus":"Not complete","administeredDoses":[{"dateAdministered":"2022-10-03T00:00:00","vaccineName":"Pfizer-BioNTech COVID-19 Vaccine (EUA labeled)  COMIRNATY (BLA labeled)","cvx":"218","mvx":"PFR","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"Pfizer-BioNTech COVID-19 Vaccine (EUA labeled)  COMIRNATY (BLA labeled)","cvx":"218","mvx":"PFR","evaluationStatus":"Not Valid","evaluationReason":"Interval: too short"}]},"forecast":{"forecastNum":"2","earliestDate":"2022-11-09T00:00:00","recommendedDate":"2022-11-09T00:00:00","pastDueDate":"2022-12-13T00:00:00"},"doses":[{"dateAdministered":"2022-10-03T00:00:00","vaccineName":"Pfizer-BioNTech COVID-19 Vaccine (EUA labeled)  COMIRNATY (BLA labeled)","cvx":"218","mvx":"PFR","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"Pfizer-BioNTech COVID-19 Vaccine (EUA labeled)  COMIRNATY (BLA labeled)","cvx":"218","mvx":"PFR","evaluationStatus":"Not Valid","evaluationReason":"Interval: too short"}],"dateAdded":"2020-10-06T20:00:00","dateUpdated":"2022-03-02T13:29:15.177","generalDescription":"This test case describes when a patient is administered the second dose of the Pfizer Covid-19 vaccine at 21 - 5 days after the first dose that the dose is not valid.","changedInVersion":"4.21","reasonForChange":"v4.21 Updated past due date to 8 weeks per 02/22/22 Clinical Considerations guidelines\nv4.15 Added a past due date.\nv4.14 Updated the test case based on new updated ACIP Guideline Recommendations (11/3/2021).  Updated test case name, age, and description from 12 to 5 years. Updated CVX Code to 218.\nv4.12 Updated per ACIP recommendations, on 09/22/2021, for Pfizer Covid-19 booster dose.\nv4.8 Changed age of patient from 16 to 12 years based on new ACIP guidelines for Pfizer vaccine eligibility."}